Clinics in Liver Disease

Scope & Guideline

Connecting researchers and clinicians for liver health advancements.

Introduction

Explore the comprehensive scope of Clinics in Liver Disease through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Clinics in Liver Disease in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1089-3261
PublisherW B SAUNDERS CO-ELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1997 to 2024
AbbreviationCLIN LIVER DIS / Clin. Liver Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899

Aims and Scopes

The journal 'Clinics in Liver Disease' aims to provide comprehensive insights and advances in the field of liver disease management, focusing on a wide range of topics including pathophysiology, diagnosis, treatment, and complications associated with liver disorders. The journal emphasizes evidence-based practices and innovative methodologies to enhance clinical care and research in hepatology.
  1. Portal Hypertension:
    The journal covers extensive research on portal hypertension, including its pathophysiology, complications, management strategies, and surgical interventions.
  2. Hepatic Encephalopathy:
    A significant focus on hepatic encephalopathy is evident, exploring its clinical manifestations, management strategies, and the socio-economic burden it imposes on healthcare systems.
  3. Autoimmune Liver Diseases:
    The journal addresses various autoimmune liver diseases such as autoimmune hepatitis and primary biliary cholangitis, focusing on their pathophysiology, diagnosis, and treatment options.
  4. Chronic Viral Hepatitis:
    Research on chronic viral hepatitis, particularly hepatitis B and C, is a core area, highlighting new therapies, epidemiology, and management challenges.
  5. Nonalcoholic Fatty Liver Disease (NAFLD):
    The journal discusses NAFLD extensively, including its epidemiology, pathogenesis, and the impact of associated conditions such as metabolic syndrome.
  6. Liver Transplantation:
    The scope includes discussions on liver transplantation, donor selection, complications, and post-transplant management, reflecting its critical role in hepatology.
  7. Acute-on-Chronic Liver Failure:
    Research on acute-on-chronic liver failure is prominent, examining its clinical spectrum, management challenges, and therapeutic innovations.
  8. Endoscopic and Interventional Procedures:
    The journal includes studies on endoscopic and interventional radiology techniques for managing liver diseases, emphasizing minimally invasive approaches.
The journal is currently witnessing a trend towards several emerging themes that reflect the evolving landscape of liver disease research and clinical practice. These themes indicate areas of growing interest and significance within the field.
  1. Noninvasive Assessment Techniques:
    There is a growing emphasis on noninvasive assessment methods for liver diseases, particularly in evaluating fibrosis and portal hypertension, as they offer safer alternatives to traditional methods.
  2. Integrated Management of Hepatic Encephalopathy:
    Increased focus on integrated management strategies for hepatic encephalopathy highlights the need for comprehensive care that addresses not only clinical symptoms but also social and economic factors.
  3. Innovative Therapies for Autoimmune Liver Diseases:
    Research into novel therapies for autoimmune liver diseases is on the rise, reflecting advancements in treatment options and a better understanding of disease mechanisms.
  4. Genetic and Metabolic Factors in Liver Disease:
    Emerging research is focusing on the genetic and metabolic underpinnings of liver diseases, particularly in relation to NAFLD and its systemic implications.
  5. Portal Hypertension Complications:
    A significant increase in studies addressing the various complications associated with portal hypertension indicates an expanding understanding and management of this complex condition.

Declining or Waning

While 'Clinics in Liver Disease' maintains a broad focus, certain themes appear to be declining in prominence, reflecting shifts in research priorities and clinical practice. The following areas have seen reduced coverage in recent publications.
  1. Traditional Hepatitis Management:
    There has been a noticeable decline in papers focusing on traditional management strategies for hepatitis, as newer, more effective treatments and approaches are being developed and adopted.
  2. Alcoholic Liver Disease Research:
    Although still relevant, the volume of research specifically addressing alcoholic liver disease has decreased, possibly due to a shift towards more comprehensive metabolic liver disease studies.
  3. Chronic Kidney Disease in Liver Disease:
    Research specifically linking chronic kidney disease with liver disease has waned, likely as more attention is directed toward integrated approaches that encompass broader aspects of liver health.
  4. Liver Biopsy Techniques:
    The frequency of papers discussing liver biopsy techniques has decreased, likely due to the increasing reliance on noninvasive diagnostic methods.
  5. Emerging Biomarkers in Liver Disease:
    Research on emerging biomarkers for liver disease diagnosis and prognosis has seen a decline, possibly overshadowed by advancements in imaging and noninvasive testing.

Similar Journals

Clinical and Molecular Hepatology

Advancing liver health through innovative research.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

Gut and Liver

Advancing knowledge in Gastroenterology and Hepatology.
Publisher: EDITORIAL OFFICE GUT & LIVERISSN: 1976-2283Frequency: 6 issues/year

Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.

LIVER INTERNATIONAL

Exploring the frontiers of liver disease and transplantation.
Publisher: WILEYISSN: 1478-3223Frequency: 12 issues/year

LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.

HEPATOLOGY RESEARCH

Exploring the frontiers of Hepatology and infectious diseases.
Publisher: WILEYISSN: 1386-6346Frequency: 12 issues/year

Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.

Hepatology Communications

Advancing liver health through innovative research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Hepatology Communications, published by Lippincott Williams & Wilkins, serves as a pioneering platform in the field of hepatology, dedicated to advancing the understanding of liver diseases and treatments. Since its inception in 2017, this open access journal has rapidly gained recognition, achieving an impressive Q1 ranking in Hepatology as of 2023, and appealing to a diverse audience of researchers, clinicians, and students alike. With its focus on high-quality research and clinical studies, the journal aims to facilitate impactful discussions and disseminate vital findings that address the challenges faced in liver health. Operating out of the United States, and accessible globally, Hepatology Communications is committed to fostering a collaborative research environment and enhancing the visibility of scholarly work in hepatology, ultimately driving forward innovations in patient care and treatment strategies.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Empowering Knowledge in Gastrointestinal and Liver Physiology
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1857Frequency: 12 issues/year

American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.

BMJ Open Gastroenterology

Driving Innovation in Gastroenterology, One Study at a Time
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

Saudi Journal of Gastroenterology

Empowering knowledge for better digestive health.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.

Korean Journal of Gastroenterology

Elevating Understanding of Gastrointestinal Disorders
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

JOURNAL OF HEPATOLOGY

Charting New Territories in Liver Health Science
Publisher: ELSEVIERISSN: 0168-8278Frequency: 12 issues/year

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.